Gold vs US Dollar

Register to chat with like-minded investors on our interactive forums.

Get Started

PRM Proteome Sciences Plc

4.15

0.64 (18.23%)

26 Apr 2024 - Closed

Delayed by 15 minutes

Proteome Sciences Investors - PRM

Share Name	Share Symbol	Market	Stock Type
Proteome Sciences Plc	PRM	London	Ordinary Share

	Price Change	Price Change %	Share Price	Last Trade
	0.64	18.23%	4.15	16:35:28

Open Price	Low Price	High Price	Close Price	Previous Close
			4.15	3.51

more quote information »

Industry Sector
PHARMACEUTICALS & BIOTECHNOLOGY

Top Investor Posts

Top Posts
Posted at 10/4/2024 10:02 by pools2 wasjobber, Thermo have been a long term partner of Proteome Sciences for 15 years, but I agree it'll be good to see Thermo taking a more prominent position. After reading the RNS this morning, the future looks brighter than ever. You've already mentioned what I think is probably the most significant RNS statement:- "It's very interesting that PRM are now openly stating that their patented Alzheimer's and cancer biomarkers may be critical to new diagnostics and treatment moving forward. STRONG BUY" It's very significant for Proteome Sciences to say that. The value of these biomarkers will be considerable and will project PRM into the £100 millions plus market cap. with ease. I think you are now correct, we are at a pivotal moment for the share price and investors buying now will achieve significant returns, possibly quicker than some may think. Read Full Thread Reply
Posted at 08/4/2024 11:19 by wasjobber The trades look like Bed & ISA's to start the new tax year. Definitely some type of 'put through' and completely market neutral. It's a sign of confidence from investors. Read Full Thread Reply
Posted at 28/3/2024 11:39 by dominiccummings #92819 Even the most experienced investors have been 'taken' by this company. Read Full Thread Reply
Posted at 14/2/2024 19:59 by peverill Does Richard not remember he sold out a few years ago,bought back in near 6p ish and now claiming he made a significant profit when the share price has been in the doldrums for the last 5 years.Even with dynamic Mrs S at the helm being unable to budge the price despite picking up over a million in wages and taking the company back 10 years and putting numerous investors on the breadline. Read Full Thread Reply
Posted at 14/2/2024 14:05 by elpirata good post pev peverill 14 Feb '24 - 13:28 - 92720 of 92720 0 1 0 Nobody hates PRM,the problem lies with the total lack of movement in the 25 years they have been on the go,30 plus years counting electrophoretics.They have achieved nothing,seen countless CEO’s come and go because their hands are tied by a clueless back staff.amassed a library of useless patents that no one needs and have a happy clapping following of equally clueless investors who’s excuses lie between it’s not happened yet and we don’t have money to progress anything but we should be worth £54 a share if we sit here and wait for someone to infringe a patent.Like I said the US move is the last throw of the dice,PRM are getting left behind by more advanced and dynamic companies. Read Full Thread Reply
Posted at 14/2/2024 13:28 by peverill Nobody hates PRM,the problem lies with the total lack of movement in the 25 years they have been on the go,30 plus years counting electrophoretics.They have achieved nothing,seen countless CEO's come and go because their hands are tied by a clueless back staff.amassed a library of useless patents that no one needs and have a happy clapping following of equally clueless investors who's excuses lie between it's not happened yet and we don't have money to progress anything but we should be worth £54 a share if we sit here and wait for someone to infringe a patent.Like I said the US move is the last throw of the dice,PRM are getting left behind by more advanced and dynamic companies. Read Full Thread Reply
Posted at 07/2/2024 10:42 by monte1 Quite, I wonder how well that strategy has worked out for previous investors? suckers Read Full Thread Reply
Posted at 07/2/2024 10:20 by wasjobber Investors need to buy these while there's no demand, otherwise they'll be paying a lot more for them after the news is released. Read Full Thread Reply
Posted at 07/2/2024 10:12 by wasjobber Proteome Sciences should get their new isotopic plexDIA reagent license deal very soon. This opens up a whole new market segment of mass spec users keen to multiplex their measurements. Of course the release of their new 32-plex TMTpro is also due soon. I don't think many investors on here have fully understood the positive implications for Proteome Sciences of all these higher plexing reagents that are imminent. STRONG BUY Read Full Thread Reply
Posted at 30/1/2024 17:27 by peverill You more than anyone have lost more money for investors with your incessant ramblings of riches to come,all the way down from the dizzy heights of its highs.Then you had the gall to sell up,buy again and claim you had a low average that was impossible to have given the time you have been here.So before claiming the high ground,just look at your history of misleading newbies and long termers alike. Read Full Thread Reply

Proteome Sciences

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions